Dyer Samuel, Hyder Cherie, Kraemer Jeff
Medical Science Liaison Society, Miami, FL 33326, USA.
Syneos Health, Morrisville, NC 27560, USA.
Pharmacy (Basel). 2025 Apr 2;13(2):51. doi: 10.3390/pharmacy13020051.
Medical Science Liaisons (MSLs) serve a vital role in facilitating the exchange of scientific knowledge between pharmaceutical companies and health care professionals (HCPs), including pharmacists, ensuring the dissemination of accurate, evidence-based information to support clinical decision-making. Evaluating MSL performance is critical for demonstrating their value, yet defining appropriate key performance indicators (KPIs) remains challenging due to the combination of scientific engagement, relationship-building, and other activities that are difficult to measure.
This study examines the current and perceived ideal use of quantitative and qualitative metrics for MSL performance evaluation, the difficulties in measuring MSL impact, and the perceived effectiveness of existing KPIs.
A global survey of 1023 medical affairs professionals across 63 countries was conducted, gathering data on which KPIs are currently used versus which should be used, the preferred weighting of qualitative vs. quantitative metrics, and opinions on measurement difficulty and KPI effectiveness.
The results reveal a strong preference for qualitative metrics (52%) over quantitative metrics (7%), though most organizations primarily use activity-based metrics such as the number of key opinion leader (KOL) engagements (92%). Despite these practices, many respondents believe that MSL KPIs should focus more on impact-based qualitative metrics, such as the quality of KOL/HCP relationships and/or engagements (70%) and the quality of actionable insights gathered (67%). Furthermore, 67% of participants reported it is "difficult" or "very difficult" to measure MSL performance accurately, and only 3% revealed current KPIs and metrics used to measure MSL performance are "very effective". These findings highlight a disconnect between the way MSLs are evaluated and the value they provide.
This study demonstrates the need for a balanced KPI framework that integrates both qualitative and quantitative measures. A more refined performance evaluation system (incorporating stakeholder feedback, insight quality, and strategic impact) can ensure fair assessments and drive MSL effectiveness.
医学科学联络官(MSL)在促进制药公司与医疗保健专业人员(HCP)之间的科学知识交流方面发挥着至关重要的作用,其中包括药剂师,确保传播准确的、基于证据的信息以支持临床决策。评估MSL的表现对于证明其价值至关重要,然而,由于科学参与、关系建立以及其他难以衡量的活动相结合,定义合适的关键绩效指标(KPI)仍然具有挑战性。
本研究探讨了目前用于以及人们认为理想的用于MSL绩效评估的定量和定性指标,衡量MSL影响的困难,以及现有KPI的感知有效性。
对63个国家的1023名医学事务专业人员进行了全球调查,收集了有关当前使用的KPI与应该使用的KPI的数据、定性与定量指标的首选权重,以及关于测量难度和KPI有效性的意见。
结果显示,与定量指标(7%)相比,人们更倾向于定性指标(52%),尽管大多数组织主要使用基于活动的指标,如关键意见领袖(KOL)互动的次数(92%)。尽管有这些做法,但许多受访者认为,MSL的KPI应更多地关注基于影响的定性指标,如KOL/HCP关系和/或互动的质量(70%)以及收集到的可操作见解的质量(67%)。此外,67%的参与者报告称准确衡量MSL绩效“困难”或“非常困难”,只有3%的人表示目前用于衡量MSL绩效的KPI和指标“非常有效”。这些发现凸显了评估MSL的方式与其提供的价值之间的脱节。
本研究表明需要一个平衡的KPI框架,将定性和定量措施结合起来。一个更完善的绩效评估系统(纳入利益相关者反馈、见解质量和战略影响)可以确保公平评估并提高MSL的有效性。